Sikiric dubbed it BPC 157. In time, it became a kind of bootleg panacea, sold by gray-market vendors to bodybuilders and biohackers, even as it struggled to win the approval of mainstream medicine
It was first developed in 1991 as a derivative of Body Protection Compound, a peptide naturally found in human gastric juices [1, 2]
One major study is looking at heart health, specifically whether CagriSema can reduce the risk of heart attacks and strokes in people with existing heart disease
the volume chosen sets the working concentration
Carry a letter from your doctor if you're concerned about questions
Preclinical research in animal models provides robust evidence for BPC-157s capacity to accelerate healing of damaged tendons, ligaments, muscle, and bone, while also protecting against gastrointestinal and neural injury